Pai Partners SAS Raises 1 Billion Euros for Debut Fund

Pai Partners SAS, a French investment firm, has made a significant move in the private equity market. They raised 1 billion euros for their debut fund.

This impressive feat is a testament to the firm's growing reputation and capabilities. The fund is expected to focus on investments in the European market.

Pai Partners SAS was founded in 2020, and this milestone marks a major step in their development as a prominent player in the industry.

A different take: Sas Criterion

PAI Partners SAS has a diverse portfolio of investments across various industries. They have a significant presence in the consumer goods sector, with notable investments in companies like Royal Canin, a leading European dry pet food manufacturer.

One of their notable investments was in Tropicana, a North American juice brand, which they acquired from PepsiCo in 2021 for $3.3 billion. This acquisition marked their largest investment to date.

In addition to consumer goods, PAI Partners has also invested in companies in the healthcare and industrial sectors. For example, they invested in Amplitude Surgical, a global surgical technology company for lower limb orthopaedics, and European Pizza Group, a frozen pizza manufacturer.

Here's a breakdown of some of their notable investments:

Their investments in the industrial sector include companies like Albéa, a global packaging company, and InnoVista Sensors (formerly CST), a sensors and control products manufacturer.

PAI Partners SAS has a long history of investing in private equity funds, with the first fund being PAI LBO Fund in 1998. This fund was a buyout fund with a total commitment of €650 million.

PAI Partners has since raised several other funds, including PAI Europe III, IV, V, and VI, all of which were also buyout funds. These funds had total commitments ranging from €1.8 billion to €3.3 billion.

The firm's most recent buyout fund, PAI Europe VII, was raised in 2018 and had a total commitment of €5.1 billion. PAI Partners also raised a mid-market fund, PAI Mid-Market, in 2020 with a total commitment of €918 million.

In a notable achievement, PAI Partners collected nearly €1 billion for its debut mid-market fund, exceeding its original target by about €220 million. This was done through a fully virtual fundraising process.

Here's a list of PAI Partners' buyout funds since inception:

PAI Partners SAS was formed in 2002 through a management buyout after the merger of Paribas and Banque Nationale de Paris (BNP).

The company's roots lie in PAI, which was the investment division of Paribas Bank.

PAI Partners focuses on leveraged buyouts with a focus on transactions valued between €300 million and several billion euros.

Their latest fund, PAI Europe VI, with a total volume of €3.3 billion, was launched in March 2015.

PAI Partners has a history of investing in German companies, including FTE, which they acquired in May 2005 and sold in May 2013, and Xella, which they acquired in August 2008 and sold in December 2016.

In 2019, they acquired 89% of the Zahneins Group, a group of dental medical care centers based in Hamburg.

In December 2020, PAI Partners acquired the facility management specialist Apleona from EQT for €1.6 billion.

PAI Partners will take over the rehabilitation centers of the Austrian Vamed group by the end of 2024.

At Pai Partners SAS, the team is made up of experienced professionals who bring a wealth of knowledge and expertise to the table.

The company's leadership team has a strong background in private equity and investment banking, with many years of experience working on complex transactions and investments.

Pai Partners SAS is a team-oriented organization that values collaboration and open communication among its employees.

A different take: Sig Sauer P365 Sas Worth

The team behind PAI Partners is comprised of experienced professionals.

Mr. Albin Louit and Mr. Andreas Kumeth both hold the job title of Partner. They are located in Paris, France and Munich, Germany respectively.

Ms. Ana Aliyari is the Principal, Consumer sector, and is also based in Paris, France.

Mr. Benjamin Mathu, Finance Director, is based in Luxembourg, Luxembourg.

Here is a list of our contacts:

Stefano Drago is a Partner at PAI, a pre-eminent private equity firm.

He played a key role in the partnership with ELITech Group, a global manufacturer of in-vitro diagnostics.

Drago expressed confidence in ELITech's future, stating that Bruker will continue the company's trajectory of innovation and leadership, supported by ELITech's excellent management team.

The partnership with ELITech has been a successful journey for PAI, driven by a wonderful team and resulting in substantial financial growth and profitability.